Translate Bio
Developing mRNA medicines to restore protein function.
Launch date
Employees
Market cap
-
Enterprise valuation
€2.9b (Public information from Aug 2021)
Share price
$37.36
Cambridge Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $2.7m | Early VC | |
$20.7m | Series A | ||
$63.8m | Series B | ||
| N/A | $51.0m | Series C | |
| N/A | $122m Valuation: $582m | IPO | |
$3.2b Valuation: $3.2b | Acquisition | ||
| Total Funding | €126m | ||